{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2","upperLimit":"5","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"}],"units":"Participants"}],"dispersionType":"Full Range","groups":[{"description":"Plerixafor 160mg/kg/dose by IV on days 5-8\n\nFilgrastim (G-CSF) 10 mg/kg/dose subcutaneously on days 1-8.","id":"OG000","title":"Plerixafor"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Duration of apheresis (up to 7 days)","title":"Median Number of Days of Apheresis","type":"SECONDARY","unitOfMeasure":"days"}